We have been attending Europe‘s largest Healthcare Conference in London, organised by Jefferies, a leading healthcare broker. The conference took place from November 20-21, 2019. Jefferies hosted 500 participating companies, 2’000 attendees and 5’000 business-to-business and investor meetings.
The conference encouraged our view of constructive prospects for the healthcare industry. Most presentations and management conversations were reassuring and signalled confidence for a continuation of the strong fundamental business trends Overall, we remain excited of what we see in the industry. From our point of view the overarching theme of the conference has been an acceleration of change across all facets of the healthcare environment.
After weeks of containment efforts, some governments dip their toe into the uncertain waters of re-opening parts of the economy. What needs to be in place in order to get back to a certain state of normalcy? And how does testing help in this endeavour?
As the world grapples with the outbreak of SARS-CoV-2 and people across the world experience dramatic cuts to their freedom of movement, the healthcare sector is racing to find solutions to tackle the current pandemic. How quickly could treatments for COVID-19 realistically become available?
We attended the 9th Annual SVB Leerink Global Healthcare Conference in New York from February 25 to 27, 2020, which hosted over 200 healthcare companies. As the spread of COVID-19 hit the markets this week, it was also the number one topic at the conference.